Home 2023

Merck KGaA

StockWatch: Insilico CEO Breaks Down Exelixis Deal
Artificial Intelligence

StockWatch: Insilico CEO Breaks Down Exelixis Deal

Alex Philippidis -
0
MilliporeSigma Grows Global Capacity to Serve Biomanufacturers
Bioprocessing

MilliporeSigma Grows Global Capacity to Serve Biomanufacturers

John Sterling -
1
MilliporeSigma Invests €35 Million in Biosafety Testing at Scotland Sites
Bioprocessing

MilliporeSigma Invests €35 Million in Biosafety Testing at Scotland Sites

John Sterling -
0
Millipore<sup>®</sup> CTDMO Services Boosts Commercial Capacity in France® CTDMO Services Boosts Commercial Capacity in France />
Bioprocessing

Millipore® CTDMO Services Boosts Commercial Capacity in France

John Sterling -
0
Knowing When to Apply Industry 4.0
Bioprocessing

Knowing When to Apply Industry 4.0

John Sterling -
0
EY Firepower Report: Biopharmas Choosing Collaborations over M&A
Drug Discovery

EY Firepower Report: Biopharmas Choosing Collaborations over M&A

Alex Philippidis -
0
Merck KGaA to Expand Aubonne, Switzerland Manufacturing Site
Bioprocessing

Merck KGaA to Expand Aubonne, Switzerland Manufacturing Site

Alex Philippidis -
0
Merck KGaA, Pfizer Join BioXcel-Nektar Collaboration, Creating Triple Combination Therapy for Pancreatic Cancer
Cancer

Merck KGaA, Pfizer Join BioXcel-Nektar Collaboration, Creating Triple Combination Therapy for Pancreatic Cancer

Alex Philippidis -
0
GSK to Co-Develop Merck KGaA’s Cancer Immunotherapy Candidate M7824 in $4.2B Alliance
Cancer

GSK to Co-Develop Merck KGaA’s Cancer Immunotherapy Candidate M7824 in $4.2B Alliance

Alex Philippidis -
0
Merck KGaA, Palantir Create Cancer Collab to Develop New Research Platform
Cancer

Merck KGaA, Palantir Create Cancer Collab to Develop New Research Platform

Steven Hernacki -
0
123...13Page 1 of 13
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.